ENDOCRINE THERAPY OF PROSTATE-CANCER - OPTIMAL FORM AND APPROPRIATE TIMING

被引：49

作者：

CRAWFORD, ED ^{[1
]}

DEANTONIO, EP ^{[1
]}

LABRIE, F ^{[1
]}

SCHRODER, FH ^{[1
]}

GELLER, J ^{[1
]}

机构：

[1] UNIV COLORADO, DENVER, CO 80202 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1995年 / 80卷 / 04期

关键词：

D O I：

10.1210/jc.80.4.1062

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1062 / 1066

页数：5

共 44 条

[1] PHARMACOLOGICAL INDUCTION OF 5-ALPHA-REDUCTASE DEFICIENCY IN THE RAT - SEPARATION OF TESTOSTERONE-MEDIATED AND 5-ALPHA-DIHYDROTESTOSTERONE-MEDIATED EFFECTS [J].

BLOHM, TR ;

LAUGHLIN, ME ;

BENSON, HD ;

JOHNSTON, JO ;

WRIGHT, CL ;

SCHATZMAN, GL ;

WEINTRAUB, PM .

ENDOCRINOLOGY, 1986, 119 (03) :959-966

[2]

BLUMENSTEIN BA, 1993, CANCER, V72, P3834, DOI 10.1002/1097-0142(19931215)72:12+<3834::AID-CNCR2820721714>3.0.CO

[3]

2-Z

[4] RESPONSE OF RAT VENTRAL PROSTATE TO A NEW AND NOVEL 5ALPHA-REDUCTASE INHIBITOR [J].

BROOKS, JR ;

BAPTISTA, EM ;

BERMAN, C ;

HAM, EA ;

HICHENS, M ;

JOHNSTON, DBR ;

PRIMKA, RL ;

RASMUSSON, GH ;

REYNOLDS, GF ;

SCHMITT, SM ;

ARTH, GE .

ENDOCRINOLOGY, 1981, 109 (03) :830-836

[5]

BRUCHOVSKY N, 1968, J BIO CHEM, V243, P3012

[6]

BRUCHOVSKY N, 1991, CANCER MED, P884

[7]

Byar D P, 1988, NCI Monogr, P165

[8]

COFFEY DS, 1978, NATL CANCER I MONOGR, V49, P289

[9]

CRAWFORD E D, 1990, Journal of Urology, V143, P221

[10]

CRAWFORD ED, 1991, UROL CLIN N AM, V18, P55

← 1 2 3 4 5 →